Vitamin D3 prevents the increase in ectonucleotidase activities and ameliorates lipid profile in type 1 diabetic rats
Authors:
- Nicéia Spanholi CalgarotoNCNicéia Spanholi Calgaroto
- Pauline da CostaPCPauline da Costa
- Andréia Machado CardosoACAndréia Machado Cardoso
- Luciane Belmonte PereiraLPLuciane Belmonte Pereira
- Juliano Marchi VieiraJVJuliano Marchi Vieira
- Diéssica DalenogareDDDiéssica Dalenogare
- Luana Paula PelinsonLPLuana Paula Pelinson
- Jucimara BaldissarelliJBJucimara Baldissarelli
- Vera Maria MorschVMVera Maria Morsch
- Maria Rosa Chitolina SchetingerMSMaria Rosa Chitolina Schetinger
- 17 April 2015
- journal article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 405 (1-2) , 11-21
Abstract
This study was designed to assess the potential effect of vitamin D3 (VD3) in avoiding atherothrombosis by modulation of lipid metabolism and platelet activation in type 1 diabetic rats. Male wistar rats were divided into eight groups (n = 5–10): Control/Saline (Sal); Control/Metformin 500 mg/kg (Metf); Control/Vitamin D3 90 µg/kg (VD3); Control/Metformin 500 mg/kg + VD3 90 µg/kg (Metf + VD3); Diabetic/Saline (Sal); Diabetic/Metformin 500 mg/kg (Metf); Diabetic/Vitamin D3 90 µg/kg (VD3); Diabetic/Metformin 500 mg/kg + VD3 90 µg/kg (Metf + VD3). Treatments were administered during 30 days after diabetes induction with streptozotocin (STZ). After 31 days, the rats were euthanized and blood was collected and separated into serum and platelets, both used for lipid profile and ectonucleotidase activity assays, respectively. Ectonucleoside triphosphate phosphohydrolase (E-NTPDase), ectonucleotide pyrophosphatase/phosphodiesterase (E-NPP), and 5′-nucleotidase and adenosine deaminase (E-ADA) were significantly higher in the Diabetic than in Control group. Treatment with Metf and/or VD3 prevented the increase in NTPDase and E-NPP activities in diabetic rats. Only Metf + VD3 significantly prevented the increase in 5′-nucleotidase. VD3 alone, but not Metf, prevented the increase in ADA activity when compared to saline-treated diabetic rats. Treatment of rats with VD3, Metf, and Metf + VD3 was also effective in the prevention of lipid metabolism disorder in diabetic and was able to ameliorate lipid metabolism in non-diabetic rats. These results provide evidence for the potential of Metf and VD3 in the treatment of platelet dysfunction and lipid metabolism impairment in T1D, which may be important in the control and prevention of atherothrombosis in diabetes.Keywords
This publication has 58 references indexed in Scilit:
- Refractory immune thrombocytopenia successfully treated with high-dose vitamin D supplementation and hydroxychloroquine: two case reportsJournal of Medical Case Reports, 2013
- Mitochondrial Localization of Vitamin D Receptor in Human Platelets and Differentiated MegakaryocytesPLOS ONE, 2010
- Association of moderate and severe hypertriglyceridemia with obesity, diabetes mellitus and vascular disease in the Spanish working population: Results of the ICARIA studyAtherosclerosis, 2009
- Effects of resveratrol on nucleotide degrading enzymes in streptozotocin-induced diabetic ratsLife Sciences, 2009
- The effect of ebselen on adenine nucleotide hydrolysis by platelets from adult ratsChemico-Biological Interactions, 2004
- Metformin decreases platelet superoxide anion production in diabetic patientsDiabetes/Metabolism Research and Reviews, 2002
- ATP-Stimulated Release of ATP by Human Endothelial CellsJournal of Cardiovascular Pharmacology, 1996
- Platelet serotonin transport is altered in streptozotocin-induced diabetic ratsLife Sciences, 1995
- On the role of insulin in regulation of adenosine deaminase activity in rat tissuesFEBS Letters, 1990
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976